Background and aims: The association of celiac disease with colorectal neoplasia is controversial. The aim of this study was to determine the risk of colorectal neoplasia among patients with celiac disease. Methods: We carried out a multicenter, retrospective case-control study, within four community hospitals. Celiac disease patients with a complete colonoscopy were regarded as cases and those without celiac disease as controls. For each case, two controls matched for age, sex, indication for colonoscopy and colorectal cancer family history, were randomly selected. The main outcome evaluated was risk of colorectal polyps, adenomas, advanced neoplastic lesions and cancer. Results: We identified 118 patients with celiac disease and 236 controls. The risk of polyps, adenomas and advanced neoplastic lesions was similar in both groups (OR 1.25, CI 0.71-2.18, p = 0.40; OR 1.39, CI 0.73-2.63, p = 0.31; and OR 1.00, CI 0.26-3.72, p = 1.00, respectively). On multivariate analysis, age N 75 years old, and first-grade CRC family history were associated with adenomas (OR 2.68 CI 1.03-6.98, OR 6.68 CI 1.03-47.98 respectively) and advanced neoplastic lesions (OR 15.03, respectively). With respect to celiac disease characteristic, a low adherence to a gluten free diet was independently associated with the presence of adenomas (OR 6.78 CI 1.39-33.20 p = 0.01).
Celiac disease (CD) is an autoimmune disorder characterized by inflammation and villous atrophy of the small intestine, resulting in malabsorption of vitamins and nutrients. 1 It is a genetically determined condition in which persons with specific human leukocyte antigen types (DQ2 or DQ8) trigger an immunologic reaction to gluten. 2 Patients with CD, particularly those not adhering to a strict gluten-free diet (GFD), are predisposed to develop many complications. Increased overall cancer mortality has been reported in adult patients with CD and even in their relatives, which supports the clinical importance of this disorder. 3, 4 Holmes et al. 5 reported an increased risk of cancers of the mouth, pharynx and esophagus, and also of lymphoma in those celiac disease patients taking a reduced gluten, or a normal diet. This result supports the protective role of GFD against malignancy in celiac disease.
The mechanism for the development of malignancies in patients with CD is not clearly known. However, increased intestinal permeability of environmental carcinogens, chronic inflammation, chronic antigenic stimulation, release of proinflammatory cytokines and nutritional deficiencies due to the disease or the GFD have been suggested. [2] [3] [4] [5] [6] Lymphomas, mostly T-cell type, and other malignant tumors, particularly adenocarcinoma of the small bowel and squamous cell carcinomas of the esophagus and pharynx have been related with CD, but the association with colorectal cancer (CRC) is not well established. [7] [8] [9] [10] [11] [12] [13] The risk of developing CRC is influenced by both environmental and genetic factors. Possibly, untreated CD is protective; dietary fat or fat soluble agents including hydrocarbons or other carcinogens may be implicated in the pathogenesis of colon cancer if poorly absorbed and rapidly excreted. 7 Alternatively, immunological changes (increased intraepithelial lymphocytosis) may prohibit development of epithelial malignancies. 8 Additional studies are needed to further clarify the association with CRC in CD patients.
Askling et al. 14 have reported an increased overall colorectal cancer risk in CD patients mainly due to an increased risk in the ascending and transverse colon. However, Freeman et al. 15 reported a low prevalence of colonic neoplasia in a retrospective observational study, and recently, Lebwohl et al. 16 found no association between CD and CRC in a case-control study.
The controversy in published studies and the low prevalence of malignancies in CD patients led us to design this multicentric case-control study.
We aimed to determine the risk of colorectal neoplasia among patients with CD by quantifying the prevalence of colorectal polyps, adenomas and advanced neoplastic lesions in these patients compared with patients without CD, and to identify celiac disease characteristics associated with these lesions.
Materials and methods
A retrospective and multicenter case-control study was conducted using the Gastroenterology and Endoscopy electronic data base of four community hospitals of Buenos Aires, Argentina (Hospital Alemán, Hospital Italiano, Hospital Austral and Hospital CEMIC). We included all patients ≥18 years old with biopsy-confirmed CD according to previously established criteria 17, 18 and who had undergone a colonoscopy. Celiac disease was defined on the basis of typical pathological features in small intestinal biopsies along with positive serologic test, consistence history and evidence for a response to a gluten-free diet. Only patients who had a complete colonoscopy (with cecal intubation), with satisfactory colonic cleansing were included for analysis. Satisfactory colonic cleansing was defined as an "excellent" or "very good quality" preparation according to a previously reported scale. 19 The following exclusion criteria were applied to all subjects: personal history of inflammatory bowel disease, CRC, familial adenomatous polyposis, hereditary non-polyposis colon cancer, colonoscopy without cecal intubation or unsatisfactory bowel cleansing. Patients with CD were regarded as cases and those without CD were regarded as controls. For each case, two controls were randomly selected and matched for age, sex, indication for colonoscopy and first-and secondgrade family history of CRC.
We collected the following data from the medical records: age, sex, medical history, purpose of colonoscopy, time since diagnosis of CD, adherence to a GFD, endoscopic diagnosis (colorectal polyps plus size and location of these lesions) and histological diagnosis (type of adenomas, dysplasia and cancer). A telephone survey was carried out to assess patients on their CRC risk factors and history of disease (diabetes mellitus, cigarette smoking, first-and second-grade colorectal polyps and colorectal cancer family history). In cases we also evaluated time since diagnosis and the adherence to a GFD. For the last purpose we used the Biagi's validated questionnaire, 20 which is based on four simple questions. The questionnaire provides a final score in five levels (0-IV), which, from a clinical point of view, can be grouped into three levels. Patients with scores of 0 or I are those who do not follow a strict GFD. Patients with scores of II, on the other hand, follow a GFD but with important errors that require correction. Patients with scores of III and IV follow a strict GFD.
The main outcome measured was the risk of colorectal polyps, adenomas, advance neoplastic lesions (ANL) (size N 1 cm, N 75% villous component and/or high-grade dysplasia) and cancer. Colorectal adenomas were classified as low-or high-grade dysplasia according to Vienna classification. 21 Patients with multiple lesions were classified according to the most advanced lesion. Enteropathy associated T cell lymphoma (EATL) and other malignancy related with CD were also addressed. Results were expressed in total number of lesions and percentage. The differences in both groups e673 Colorectal adenomas in celiac disease patients were calculated using the chi-square test. For all analyses, significance was considered with a p value b 0.05 level or a confidence interval of 95%. Risk was expressed in odds ratio (OR) and its corresponding confidence intervals (CIs) 95%.
We performed a univariate and logistic regression multivariate analysis to identify all variables independently associated with the presence of colorectal neoplasia. Assuming that malignancy may be related to disease duration and to GFD adherence, we also evaluated the relation between time since diagnosis and adherence to GFD with the presence of colorectal neoplasia. All statistic calculation was performed using statistical software SPSS windows 10.0. The protocol was approved by our institution's Human Ethics Committee.
Results
During the analyzed period, we identified 118 celiac disease patients who had undergone a previous colonoscopy and were included in the study as cases and 236 as controls. Characteristics of the CD patients and controls are listed in Table 1 .
In cases, the average age was 56 (range 22-87), 84% were women, 6% were diabetic and 13% were cigarette smokers. 19.5% of the cases had a CRC family history, and 4% had a colonic polyp family history. The main indication for colonoscopy was CRC screening in 53%, and the other purposes for colonoscopy were anemia in 15%, abdominal pain in 12%, diarrhea in 10% and family history of CRC in 4%. In CD patients, 65% followed a strict GFD (scores III or IV), 20% did not follow a strict GFD (scores of 0 or I), and 15% followed a GFD but with important errors that require correction (score II). In regards to time since diagnosis of CD, 41% have between 5 and 10 years since diagnosis, 32% less than 5 years and 27% have more than 10 years since diagnosis.
Presence of polyps, adenomas and ANL in CD patients was 24/118 (20%), 18/118 (15%) and 3/118 (2.5%), respectively. The results are listed in Table 2 . Only 1of the 118 (0.8%) celiac disease patients presented enteropathy associated T cell lymphoma (EATL). EATL developed in one patient with a low-adherence to a GFD (score 0-I-II) 1/41 (2.4%) 8 years after initial diagnosis. None of the patient with a strict adherence to a GFD 0/77 (0%) developed lymphoma or malignancy. This difference between different groups didn't reached a statistical significance (p N 0.05).
In controls, the average age was 56 (range 20-87) and 84% were women, 3% were diabetic and 19% were cigarette smokers. Nineteen per cent of controls had a family history of CRC, and 13.5%, a family history of colonic polyps. The indication for colonoscopy was CRC screening in 51% and anemia in 28%.
Presence of polyps, adenomas and ANL in patients without CD was 40/236 (17%), 27/236 (11%) and 6/236 (2.5%), respectively. Table 3) .
With respect to CD characteristics, a low adherence to GFD (level 0-I of Biagi's score) was significantly associated with adenomas (OR 6.78, CI 1.39-33.20) on the multivariate analysis (Table 4) . We found no association between time since diagnosis and adherence to GFD.
Discussion
In this multicenter retrospective case-control study, the prevalence of colonic polyps, adenomas and ANL in patients with CD was not significantly different from non-CD patients, but we observed that those patients without a strict adherence to a GFD have an increased risk for adenomas. As in this cohort of CD patients, most of them (65%) were strictly adherent to a GFD, and we don't know if this null risk of colorectal neoplasia will remain in a future larger cohort with a higher prevalence of non-adherents to a GFD.
Our results are congruent with previous studies. Lebwohl et al. 16 also compared the prevalence of colorectal adenomas in 180 CD patients and in 346 controls in a recent large e675 Colorectal adenomas in celiac disease patients colorectal neoplasia in CD patients with a multicenter design, addressing the most important CRC risk factors and celiac disease characteristics.
In our study, the prevalence of ANL was 2.5%, whereas others typically report from 5.6% to 10.6%. [22] [23] [24] [25] Two issues may have contributed to the lower prevalence observed in our study than in most of the other studies. First, women were predominant in our study, unlike in other screening studies. [21] [22] [23] [24] [25] The study by Schoenfeld et al., which included only women, reported a prevalence of advanced neoplasia as low as 4.9%. 27 Secondly, even though the media age in our study was 56 years old; we have a great proportion of young patients (27.4% of patients younger than 50 years old). In our study, 10.7% of the patients had a first-grade CRC family history, values similar to those reported in many previously published studies. [23] [24] [25] [26] [27] [28] As the main outcome measured in this study (risk of polyps, adenomas and ANL) is directly related to previously established risk factors (age, gender, family history of CRC and purpose of colonoscopy), we think it's crucial to know patient's CRC risk factor in order to achieve a non-biased comparison. For this reason, we carried out a telephone survey in order to assess all patients on their CRC risk factors. With this information in hand, we were able to match each celiac patient with two non-celiac patients adjusting for the most important CRC risk factors: age, sex, purpose for colonoscopy and first-and second-grade CRC family history.
Non-adherence to GFD and long CD duration have been previously related to an increased mortality and celiac disease complications such as malignancy. 7, 8 In order to evaluate the GFD, we applied the Biagi validated questionnaire. This score has been validated not only with histology and serologic markers, but also with celiac disease mortality and its complications. 20 We found that a non-strict adherence to a GFD (scores 0-I of the Biagi's score) was independently associated with the presence of adenomas on the multivariate analysis (OR: 6.78 (CI 1.39-33.20) p 0.01). We didn't find a significant association between CD duration and the presence of polyps, adenomas or ANL. Even though there wasn't a significant statistical difference in colorectal neoplasia prevalence between celiac patients and controls, we found that CD patients with a non-strict adherence to GFD have a greater risk for presenting adenomas. The fact that the CD population studied in this cohort was mostly strict GFD adherent (65%), and only a small percentage of patients were non-strict adherent to GFD could lead to statistical underpowered estimation. Further larger studies addressing GFD adherence are needed to confirm this observation.
We also found a low prevalence of other related malignancy among CD patients 1/118 (0.84%). Only one patient with a low-adherence to a GFD developed EATL (2.4%) and no carcinoma was reported. We didn't find a statistical significant difference between EATL prevalence between strict-and low-adherents to a GFD, but we are aware that our study was not powered to detect differences in this outcome. This study's main potential limitations are the retrospective design and the low event rates of hard end points such as cancer. Referral bias is likely to have occurred because the four institutions participating have a particular interest for CD. A selection bias is also likely because all the patients included have a follow-up data and a complete colonoscopy with a satisfactory colonic cleansing. The telephone survey assessing patients' risk factors and disease information, the utilization of validated tools (adherence to GFD and colonic preparation) and finally the multicenter design were planned to minimize bias. In another effort to minimize the potential confounder with the outcomes of adenomas and ANL, we performed a multivariate analysis with all the addressed variables and with CD also as a covariate. CD was not associated with an increased odd for colonic polyps, adenoma or ANL. Age N 75 years old and first-grade family history of neoplasia were independently associated with adenomas (OR 2.68 CI 1.03-6.98, OR 6.68 CI 1.03-47.98 respectively) and with ANL (OR 15.03 CI 2.88-78.3, OR 6.46 CI 1.23-33.79). Previous studies have established these two finding as the most important predictors of adenomas and CRC. 28 These results show that this cohort may be representative of the general populations undergoing a colonoscopy.
In summary, our study didn't show a greater risk of colorectal neoplasia in patients with celiac disease. Non-strict adherence to a GFD was an independent predictor for the presence of adenomas. If these finding are confirmed in future larger cohort studies with a higher prevalence of patients Table 4 Risks factors for colorectal neoplasia among celiac disease patients (multivariate analysis).
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